Apert syndrome
MONDO:0007041Apert syndrome (AS) is a frequent form of acrocephalosyndactyly, a group of inherited congenital malformation disorders, characterized by craniosynostosis, midface hypoplasia, and finger and toe anomalies and/or syndactyly.
Also known as: ACS1, Apert syndrome, acrocephalosyndactyly type 1, acrocephalosyndactyly type I, type I Acrocephalosyndactyly, ACS 1, ACS 2, Apert-Crouzon disease
12 clinical trials for this condition and its sub-types, 11 tagged with Apert syndrome itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Apert syndrome
-
Maroteaux Fonfria syndrome 0 trials
-
New drug combo targets tough breast cancer in early trial
Disease control CompletedThis early-phase study tests a new drug called E7090, alone or with other cancer medicines, in people with a common type of advanced breast cancer (ER+, HER2-). The main goal is to find safe doses and understand side effects. About 51 participants will take part to guide future r…
Phase 1 • Sponsor: Eisai Co., Ltd. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Targeted drug shows promise for rare bile duct cancer
Disease control CompletedThis study tested an experimental drug called E7090 in 63 people with advanced bile duct cancer that has a specific genetic change (FGFR2 fusion). Participants had already tried chemotherapy without success. The goal was to see if the drug could shrink tumors. Results help determ…
Phase 2 • Sponsor: Eisai Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC